Drug intelligence / Profile preview

s-KL

Development stage
Preclinical
Lead developer
Anew Medical
Modality
Cell Therapies, Gene Therapies, Recombinant Proteins and Enzymes
Administration
Injection, Intracerebroventricular
01

Overview

s-KL (secreted Klotho) is a secreted isoform of the alphaKlotho protein, an aging suppressor. It is a 70 kDa protein that exerts pleiotropic beneficial properties by modulating insulin, insulin-like growth factor-1 (IGF-1), and Wnt signaling pathways, while also reducing inflammatory and oxidative stress. It has demonstrated therapeutic potential in preclinical models for enhancing remyelination by oligodendrocytes in multiple sclerosis, improving physical fitness, bone microstructure, and cognitive functions in aging, and inhibiting osteogenic differentiation in renal interstitial biomineralization. Delivery methods explored include adeno-associated virus (AAV) vectors and mesenchymal stem cells (MSCs) transduced with s-KL.

Other names
secreted klothosoluble klothosecreted isoform KlothoalphaKlotho isoform
02

Targets

FGF23 (Fibroblast growth factor 23)IGF-1R (Insulin-like growth factor 1 receptor)KCNJ1 (Kir1.1)TGFBR2 (TGF-β receptor type 2)TRPV (TRPV channel family)Wnt (Wnt ligand)

Beyond the preview

Go deeper on s-KL.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on s-KL.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call